This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2024
AMA 2024
ASCO 2024
AUA 2024
APCCC 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Abiraterone acetate: A novel therapeutic option in hormone-refractory prostate cancer - Abstract
May 16, 2012
What management for the asymptomatic men carriers of BRCA1 or 2 mutation? Results of a survey in the French oncogenetic centers - Abstract
May 16, 2012
Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer - Abstract
May 16, 2012
Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy - Abstract
May 16, 2012
Technical refinement and learning curve for attenuating neurapraxia during robotic-assisted radical prostatectomy to improve sexual function - Abstract
May 16, 2012
Optimizing the care of patients with advanced prostate cancer in the UK: Current challenges and future opportunities - Abstract
May 16, 2012
Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: New insights attained by mass spectrometry - Abstract
May 15, 2012
A critical assessment of post-prostatectomy prostate specific antigen doubling time acceleration-is it stable? - Abstract
May 15, 2012
Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance - Abstract
May 15, 2012
Radical prostatectomy outcome in men 65 years old or older with low risk prostate cancer - Abstract
May 15, 2012
A contemporary update on pathology reporting for prostate cancer: Biopsy and radical prostatectomy specimens - Abstract
May 15, 2012
Classifying prostate cancer malignancy by quantitative histomorphometry - Abstract
May 15, 2012
International variation in prostate cancer incidence and mortality rates - Abstract
May 15, 2012
Introducing parametric fusion PET/MRI of primary prostate cancer - Abstract
May 15, 2012
Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses - Abstract
May 15, 2012
Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy - Abstract
May 15, 2012
Racial/Ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population - Abstract
May 14, 2012
Is sampling transitional zone in patients who had prior negative prostate biopsy necessary? - Abstract
May 14, 2012
Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis - Abstract
May 14, 2012
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer - Abstract
May 14, 2012
Page 1266 of 1407
Start
Prev
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free